HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 572835Generated: October 30, 2026
HCID 56947871, compound → HCID 56948114, compound
https://huagongshe.com/reaction/572835
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 56947871 | HCID 56947871 | — |
| Reactant | HCID 178418265 | HCID 178418265 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Solvent | N-methyl-2-pyrrolidone | HCID 13387 | — |
| Product | HCID 56948114 | HCID 56948114 | — |
Reaction Steps
To a mixture of trifluoromethanesulfonic acid 3-[benzothiazol-2-yl(1-methylpiperidin-4-yloxy)methyl]phenyl ester (110 mg) and ferric acetylacetonate (4 mg) in a mixture of tetrahydrofurane (4.5 mL) and N-methylpyrrolidone (0.25 mL) cooled at 0° C. is added a 2M solution of butylmagnesium chloride in tetrahydrofurane (150 μL). The mixture is stirred at room temperature for 25 min, then warmed at 30° C. for 15 min. A second addition of butylmagnesium chloride in tetrahydrofurane (150 μL) is performed. The mixture is then diluted with diethyl ether and quenched with 0.5N hydrochloric solution. The aqueous phase is extracted with diethyl ether, then ethyl acetate. Organic phases are pooled, dried over magnesium sulfate and concentrated under reduced pressure. The residue is purified by chromatography (gradient heptane/ethyl acetate from 99/1 to 90/10). The product is then refluxed in methanol and concentrated to give 2-[(3-butylphenyl)(1-methylpiperidin-4-yloxy)methyl]benzothiazole.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09029357B2 |
|---|
| Source dataset | uspto-grants-2015_05 |
|---|
| ORD ID | ord-780a03d64a8e4de3bf5a863486241212 |
|---|
| Source note | uspto-grants-2015_05 |
|---|